MPH Health Care AG AI Stock Analysis
Want to see DE:93M1 full AI Analyst Report?
MPH Health Care AG (93M1) AI Stock Analysis
MPH Health Care AG
(XETRA:93M1)
The overall score is driven by a highly attractive valuation with an extremely low P/E and massive dividend yield, supported by strong bullish technical trends. However, the score is significantly constrained by poor financial performance, specifically the alarming lack of cash flow conversion from reported earnings, which raises substantial sustainability concerns.
MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 132.72M
- Dividend Yield
- 16.13%
- Average Volume (3M)
- 2,517
- Price to Earnings (P/E)
- 1.2
- Beta (1Y)
- 0.72
- Revenue Growth
- -62.35%
- EPS Growth
- ―
- Country
- Germany
- Employees
- 2
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
MPH Health Care AG Business Overview & Revenue Model
Company Description
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and vario...
How the Company Makes Money
MPH Health Care AG primarily makes money through its role as a holding company that owns stakes in healthcare-related businesses. Its earnings are typically generated from (1) dividends and profit distributions received from portfolio companies (when...
MPH Health Care AG Financial Statement Overview
Summary
Profitability and a strong balance sheet are offset by extremely weak cash flow conversion. Net income is stable, but operating cash flow covers less than 1% of earnings, severely undermining financial quality.
Income Statement
65PositiveBalance Sheet
80PositiveCash Flow
20Very Negative| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 358.93M | 364.30M | 6.11M | 7.24M | 6.85M | 4.36M |
| Gross Profit | 358.90M | 364.30M | 6.11M | 125.94M | 6.80M | 4.01M |
| EBITDA | 112.79M | 34.10M | 33.32M | 30.36M | 29.68M | -9.05M |
| Net Income | 107.05M | 29.30M | 32.04M | 29.54M | 29.11M | -8.96M |
Balance Sheet | ||||||
| Total Assets | 266.68M | 258.09M | 291.06M | 266.35M | 236.99M | 198.00M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 1.37M | 1.20M | 5.10M | 3.82M | 4.44M |
| Total Debt | 15.37M | 11.63M | 10.56M | 13.05M | 12.99M | 4.05M |
| Total Liabilities | 18.27M | 14.68M | 13.19M | 15.39M | 15.57M | 5.69M |
| Stockholders Equity | 248.41M | 243.41M | 277.87M | 250.97M | 221.42M | 192.31M |
Cash Flow | ||||||
| Free Cash Flow | 0 | 123.01K | 1.83M | -2.02M | -170.41K | -1.28M |
| Operating Cash Flow | 11.02M | 130.88K | 1.83M | -2.02M | -164.79K | -1.28M |
| Investing Cash Flow | -3.79M | -3.29M | 3.40M | 5.40M | -8.96M | 6.37M |
| Financing Cash Flow | -11.85M | -6.85M | -7.70M | 7.74M | -3.02M | -3.61M |
MPH Health Care AG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Positive. The current price of 31.00 is above the 20-day moving average (MA) of 30.10, above the 50-day MA of 28.39, and above the 200-day MA of 22.75, indicating a bullish trend. The MACD of 1.37 indicates Negative momentum. The RSI at 55.03 is Neutral, neither overbought nor oversold. The STOCH value of 73.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:93M1.
MPH Health Care AG Peers Comparison
Overall Rating
DE:93M166Neutral
DE:DMP54Neutral
DE:B8FK53Neutral
DE:EVT42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 66Neutral | EUR 132.72M | 1.24 | 43.53% | 16.13% | -62.35% | ― | |
| 54Neutral | EUR 1.62B | 13.05 | 20.60% | 2.69% | 1.71% | 15.95% | |
| 53Neutral | EUR 17.08M | -1.32 | -110.30% | ― | ― | ― | |
| 42Neutral | EUR 445.22M | -2.46 | -25.63% | ― | -5.03% | -13.63% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:93M1 | MPH Health Care AG | 31.00 | 15.34 | 97.92% | |
| DE:B8FK | Biofrontera AG | 2.81 | 0.07 | 2.55% | |
| DE:EVT | Evotec AG (UK) | 2.51 | -2.79 | -52.72% | |
| DE:PA8 | PAION AG | 0.04 | 0.03 | 275.00% | |
| DE:DMP | Dermapharm Holding | 32.75 | -1.80 | -5.21% | |
| DE:SBX | SynBiotic SE | 0.11 | -1.98 | -94.55% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
